← FDA DRUG APPROVALS

FDA ANDA · ANDA040302

LIDOCAINE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA040302
TYPE
ANDA
ORIGINAL APPROVAL
1998-09-28
LATEST ACTION
2020-03-16
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINERPrescription
LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINERPrescription
LIDOCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION

Approval history

2020-03-16Labeling · Supplement 16 · standardAP
2002-12-04Labeling · Supplement 1AP
1998-09-28OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →